Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells
- 26 April 2010
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (19), 8736-8741
- https://doi.org/10.1073/pnas.0906126107
Abstract
Chemokines are known to regulate the steady-state and inflammatory migration of cutaneous dendritic cells (DCs). The beta-chemokine CCL17, a ligand of CCR4, is inducibly expressed in a subset of DCs and is strongly up-regulated in atopic diseases. Using an atopic dermatitis model, we show that CCL17-deficient mice develop acanthosis as WT mice, whereas dermal inflammation, T helper 2-type cytokine production, and the allergen-specific humoral immune response are significantly decreased. Notably, CCL17-deficient mice retained Langerhans cells (LCs) in the lesional skin after chronic allergen exposure, whereas most LCs emigrated from the epidermis of allergen-treated WT controls into draining lymph nodes (LNs). Moreover, CCL17-deficient LCs showed impaired emigration from the skin after exposure to a contact sensitizer. In contrast, the absence of CCR4 had no effect on cutaneous DC migration and development of atopic dermatitis symptoms. As an explanation for the major migratory defect of CCL17-deficient DCs in vivo, we demonstrate impaired mobility of CCL17-deficient DCs to CCL19/21 in 3D in vitro migration assays and a blockade of intracellular calcium release in response to CCR7 ligands. In addition, responsiveness of CCL17-deficient DCs to CXCL12 was impaired as well. We demonstrate that the inducible chemokine CCL17 sensitizes DCs for CCR7- and CXCR4-dependent migration to LN-associated homeostatic chemokines under inflammatory conditions and thus plays an important role in cutaneous DC migration.Keywords
This publication has 45 references indexed in Scilit:
- Basis for the barrier abnormality in atopic dermatitis: Outside-inside-outside pathogenic mechanismsJournal of Allergy and Clinical Immunology, 2008
- CD24a Expression Levels Discriminate Langerhans Cells from Dermal Dendritic Cells in Murine Skin and Lymph NodesJournal of Investigative Dermatology, 2008
- PGE2-induced metalloproteinase-9 is essential for dendritic cell migrationBlood, 2008
- CXCL12-CXCR4 Engagement Is Required for Migration of Cutaneous Dendritic CellsThe American Journal of Pathology, 2007
- CCL17 transgenic mice show an enhanced Th2‐type response to both allergic and non‐allergic stimuliEuropean Journal of Immunology, 2006
- Skin homing of Langerhans cell precursors: Adhesion, chemotaxis, and migrationJournal of Allergy and Clinical Immunology, 2006
- CHEMOKINES, SPHINGOSINE-1-PHOSPHATE, AND CELL MIGRATION IN SECONDARY LYMPHOID ORGANSAnnual Review of Immunology, 2005
- The Inducible CXCR3 Ligands Control Plasmacytoid Dendritic Cell Responsiveness to the Constitutive Chemokine Stromal Cell–derived Factor 1 (SDF-1)/CXCL12The Journal of Experimental Medicine, 2003
- Compartmentalized Production of CCL17 In VivoThe Journal of Experimental Medicine, 2003
- CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed SkinThe Journal of Experimental Medicine, 2001